Salvage chemotherapy with weekly paclitaxel for metastatic melanoma
dc.authorscopusid | 55402747600 | |
dc.authorscopusid | 35363563100 | |
dc.authorscopusid | 55349813400 | |
dc.authorscopusid | 36112602800 | |
dc.authorscopusid | 24079940000 | |
dc.contributor.author | Ozaslan E. | |
dc.contributor.author | Aksoy A. | |
dc.contributor.author | Gumusay O. | |
dc.contributor.author | Arpaci E. | |
dc.contributor.author | Berk V. | |
dc.date.accessioned | 2024-08-04T20:02:26Z | |
dc.date.available | 2024-08-04T20:02:26Z | |
dc.date.issued | 2015 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.doi | 10.7314/APJCP.2015.16.6.2581 | |
dc.identifier.endpage | 2581 | en_US |
dc.identifier.issn | 1513-7368 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 25824800 | en_US |
dc.identifier.scopus | 2-s2.0-84929223642 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 2581 | en_US |
dc.identifier.uri | https://doi.org/10.7314/APJCP.2015.16.6.2581 | |
dc.identifier.uri | https://hdl.handle.net/11616/91694 | |
dc.identifier.volume | 16 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Asian Pacific Organization for Cancer Prevention | en_US |
dc.relation.ispartof | Asian Pacific Journal of Cancer Prevention | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | antineoplastic agent | en_US |
dc.subject | paclitaxel | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | female | en_US |
dc.subject | follow up | en_US |
dc.subject | human | en_US |
dc.subject | male | en_US |
dc.subject | melanoma | en_US |
dc.subject | middle aged | en_US |
dc.subject | mortality | en_US |
dc.subject | prognosis | en_US |
dc.subject | salvage therapy | en_US |
dc.subject | survival rate | en_US |
dc.subject | Adult | en_US |
dc.subject | Aged | en_US |
dc.subject | Antineoplastic Agents, Phytogenic | en_US |
dc.subject | Female | en_US |
dc.subject | Follow-Up Studies | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Melanoma | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Paclitaxel | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Salvage Therapy | en_US |
dc.subject | Survival Rate | en_US |
dc.title | Salvage chemotherapy with weekly paclitaxel for metastatic melanoma | en_US |
dc.type | Letter | en_US |